Gerrit Dispersyn is President & CEO of Phio Pharmaceuticals Corp.. Currently has a direct ownership of 212,327 shares of PHIO, which is worth approximately $734,651. The most recent transaction as insider was on Mar 01, 2022, when has been sold 8,954 shares (Common Stock, $0.0001 par value) at a price of $0.82 per share, resulting in proceeds of $7,342. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 212K
0% 3M change
0% 12M change
Total Value Held $734,651

Gerrit Dispersyn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2022
SELL
Payment of exercise price or tax liability
$7,342 $0.82 p/Share
8,954 Reduced 4.05%
212,327 Common Stock, $0.0001 ...
Feb 15 2022
BUY
Grant, award, or other acquisition
-
126,000 Added 36.28%
221,281 Common Stock, $0.0001 ...
Aug 16 2021
BUY
Open market or private purchase
$9,780 $1.63 p/Share
6,000 Added 5.92%
95,281 Common Stock, $0.0001 ...
Mar 04 2021
BUY
Open market or private purchase
$5,000 $2.56 p/Share
1,953 Added 2.14%
89,281 Common Stock, $0.0001 ...
Mar 03 2021
BUY
Open market or private purchase
$7,575 $3.03 p/Share
2,500 Added 2.78%
87,328 Common Stock, $0.0001 ...
Mar 01 2021
BUY
Grant, award, or other acquisition
-
68,450 Added 44.66%
84,828 Common Stock, $0.0001 ...
GD

Gerrit Dispersyn

President & CEO
Marlborough, MA

Track Institutional and Insider Activities on PHIO

Follow Phio Pharmaceuticals Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHIO shares.

Notify only if

Insider Trading

Get notified when an Phio Pharmaceuticals Corp. insider buys or sells PHIO shares.

Notify only if

News

Receive news related to Phio Pharmaceuticals Corp.

Track Activities on PHIO